Detalhe da pesquisa
1.
Epigenomic translocation of H3K4me3 broad domains over oncogenes following hijacking of super-enhancers.
Genome Res
; 32(7): 1343-1354, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34933939
2.
Chromothripsis as a pathogenic driver of multiple myeloma.
Semin Cell Dev Biol
; 123: 115-123, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33958284
3.
A NOTCH3-CXCL12-driven myeloma-tumor niche signaling axis promotes chemoresistance in multiple myeloma.
Haematologica
; 2024 Feb 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38385272
4.
Pharmacologic targeting of the p62 ZZ domain enhances both anti-tumor and bone-anabolic effects of bortezomib in multiple myeloma.
Haematologica
; 2023 Nov 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37981834
5.
Molecular characterization and clinical outcome of B-cell precursor acute lymphoblastic leukemia with IG-MYC rearrangement.
Haematologica
; 108(3): 717-731, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35484682
6.
FiNGS: high quality somatic mutations using filters for next generation sequencing.
BMC Bioinformatics
; 22(1): 77, 2021 Feb 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33602113
7.
Differential RNA splicing as a potentially important driver mechanism in multiple myeloma.
Haematologica
; 106(3): 736-745, 2021 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32079689
8.
Monitoring treatment response and disease progression in myeloma with circulating cell-free DNA.
Eur J Haematol
; 106(2): 230-240, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33107092
9.
TarPan: an easily adaptable targeted sequencing panel viewer for research and clinical use.
BMC Bioinformatics
; 21(1): 144, 2020 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32293247
10.
Bone marrow microenvironments that contribute to patient outcomes in newly diagnosed multiple myeloma: A cohort study of patients in the Total Therapy clinical trials.
PLoS Med
; 17(11): e1003323, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33147277
11.
Microhomology-mediated end joining drives complex rearrangements and overexpression of MYC and PVT1 in multiple myeloma.
Haematologica
; 105(4): 1055-1066, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31221783
12.
Clonal evolution in myeloma: the impact of maintenance lenalidomide and depth of response on the genetics and sub-clonal structure of relapsed disease in uniformly treated newly diagnosed patients.
Haematologica
; 104(7): 1440-1450, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30733268
13.
Clonal selection and double-hit events involving tumor suppressor genes underlie relapse in myeloma.
Blood
; 128(13): 1735-44, 2016 09 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-27516441
14.
High-risk transcriptional profiles in multiple myeloma are an acquired feature that can occur in any subtype and more frequently with each subsequent relapse.
Br J Haematol
; 195(2): 283-286, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34244996
15.
Enhancing cancer clonality analysis with integrative genomics.
BMC Bioinformatics
; 16 Suppl 13: S7, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26424171
16.
The genomic landscape of plasma cells in systemic light chain amyloidosis.
Blood
; 132(26): 2775-2777, 2018 12 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-30446495
17.
Bispecific BCMA/CD24 CAR-T cells control multiple myeloma growth.
Nat Commun
; 15(1): 615, 2024 Jan 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38242888
18.
New enumeration algorithm for protein structure comparison and classification.
BMC Genomics
; 14 Suppl 2: S1, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23445440
19.
Expression of integrin ß-7 is epigenetically enhanced in multiple myeloma subgroups with high-risk cytogenetics.
Clin Epigenetics
; 15(1): 18, 2023 02 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36737807
20.
High NEK2 expression in myeloid progenitors suppresses T cell immunity in multiple myeloma.
Cell Rep Med
; 4(10): 101214, 2023 10 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37794587